Clinical Trials
| Cancer Type: Breast | |
| Description: Endocrine Therapy With or Without Inhibition of EGF and HER2 Growth Factor Receptors: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial for Postmenopausal Women with Estrogen-Receptor Positive Advanced Breast Cancer |
|
| Entity Approving The Trial: Cancer and Leukemia Group B (CALGB) |
|
| Phase: III | |
| Site-Wide Accrual Goal: 324 | |
| Related Files | |
| No related files found. | |
| Related Links | |
| http://www.cancer.gov/search/viewclinicaltrials.aspx?version=healthprofessional&cdrid=510452 |
 |
 |
|
